Cart
sales@molnova.com
PLX-8394
CAS No. 1393466-87-9
PLX-8394( PLX 8394 )
Catalog No. M11639 CAS No. 1393466-87-9
A potent and selective Raf inhibitor with biochemical IC50 of 3.8/14/23 nM for BRaf V600E/BRAF/CRAF, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 60 | In Stock |
|
| 2MG | 31 | In Stock |
|
| 5MG | 49 | In Stock |
|
| 10MG | 90 | In Stock |
|
| 25MG | 150 | In Stock |
|
| 50MG | 249 | In Stock |
|
| 100MG | 449 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePLX-8394
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective Raf inhibitor with biochemical IC50 of 3.8/14/23 nM for BRaf V600E/BRAF/CRAF, respectively.
-
DescriptionA potent and selective Raf inhibitor with biochemical IC50 of 3.8/14/23 nM for BRaf V600E/BRAF/CRAF, respectively; shows pERK inhibition in A375 and COLO829 cells with IC50 of 3.5 nM and 2.1 nM, respectively; and do not elicit paradoxical ERK1/2 activation in mutant RAS expressing cells; exhibits effectivity in both BRAFV600E and certain non-V600 LA models, in vitro and in vivo.Skin Cancer Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsPLX 8394
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorBRAFV600E|BRAF
-
Research AreaCancer
-
IndicationSkin Cancer
Chemical Information
-
CAS Number1393466-87-9
-
Formula Weight542.5328
-
Molecular FormulaC25H21F3N6O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 39 mg/mL
-
SMILESO=S(N1C[C@H](F)CC1)(NC2=CC=C(F)C(C(C3=CNC4=NC=C(C5=CN=C(C6CC6)N=C5)C=C43)=O)=C2F)=O
-
Chemical Name1-Pyrrolidinesulfonamide, N-[3-[[5-(2-cyclopropyl-5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-3-fluoro-, (3R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tutuka CSA, et al. Mol Cancer. 2017 Jun 28;16(1):112.
2. Zhang C, et al. Nature. 2015 Oct 22;526(7574):583-6.
3. Okimoto RA, et al. Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13456-13461.
molnova catalog
related products
-
Balamapimod
Balamapimod (MKI-833) is an orally active, reversible Ras/Raf/MEK inhibitor developed for antineoplastic potential.
-
I-49 free base
I-49 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.
-
B-Raf IN 15
B-Raf IN 15 is a BRAF inhibitor that inhibits BRAFWT and BRAFV600E and can be used in the study of melanoma and cancer, and can be optimized for use as a more effective BRA F inhibitor.
